Association with membrane protrusions makes ErbB2 an internalization-resistant receptor.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Molecular Biology of the Cell

• Publication date

  2004-01-23

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1091/MBC.E03-08-0596PMID 14742716PMCID PMC379255
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effect of Clathrin Heavy Chain- and α-Adaptin-specific Small Inhibitory RNAs on Endocytic Accessory Proteins and Receptor Trafficking in HeLa Cells*

  2003cited by this paper
• An open-and-shut case? Recent insights into the activation of EGF/ErbB receptors.

  2003cited by this paper
• Microvillar Membrane Microdomains Exist at Physiological Temperature

  2003cited by this paper
• Cortactin Is a Component of Clathrin-Coated Pits and Participates in Receptor-Mediated Endocytosis

  2003cited by this paper
• Impairing actin filament or syndapin functions promotes accumulation of clathrin-coated vesicles at the apical plasma membrane of acinar epithelial cells.

  2003cited by this paper
• Quantitative Analysis of HER2-mediated Effects on HER2 and Epidermal Growth Factor Receptor Endocytosis

  2003cited by this paper
• The deaf and the dumb: the biology of ErbB-2 and ErbB-3.

  2003cited by this paper
• Biologic and therapeutic role of HER2 in cancer

  2003cited by this paper
• Coregulation of epidermal growth factor receptor/human epidermal growth factor receptor 2 (HER2) levels and locations: quantitative analysis of HER2 overexpression effects.

  2003cited by this paper
• Triton promotes domain formation in lipid raft mixtures.

  2002cited by this paper
• Signal transduction and endocytosis: close encounters of many kinds

  2002cited by this paper
• Cancer cell motility--on the road from c-erbB-2 receptor steered signaling to actin reorganization.

  2002cited by this paper
• Lipid rafts and the local density of ErbB proteins influence the biological role of homo- and heteroassociations of ErbB2

  2002influential reference
• TCR signal initiation machinery is pre‐assembled and activated in a subset of membrane rafts

  2002cited by this paper
• Dynamics of plasma membrane microdomains and cross‐talk to the insulin signalling cascade

  2002cited by this paper
• Membrane traffic exploited by protein toxins.

  2002cited by this paper
• Sequestration of Epidermal Growth Factor Receptors in Non-caveolar Lipid Rafts Inhibits Ligand Binding*

  2002cited by this paper
• Regulation of Growth Factor Receptors by Gangliosides

  2002cited by this paper
• Trastuzumab (herceptin), a humanized anti-Her2 receptor monoclonal antibody, inhibits basal and activated Her2 ectodomain cleavage in breast cancer cells.

  2001influential reference
• Heregulin-dependent translocation and hyperphosphorylation of ErbB-2

  2001cited by this paper
• The Role of c-erbB-2/HER2/neu in Breast Cancer Progression and Metastasis

  2001cited by this paper
• Untangling the ErbB signalling network

  2001cited by this paper
• Biology of HER2 and Its Importance in Breast Cancer

  2001influential reference
• The basic biology of HER2.

  2001cited by this paper
• Tumor-inhibitory antibodies to HER-2/ErbB-2 may act by recruiting c-Cbl and enhancing ubiquitination of HER-2.

  2000cited by this paper
• Lipid rafts and signal transduction

  2000influential reference
• Molecular requirements for the effect of neuregulin on cell spreading, motility and colony organization

  2000cited by this paper
• Structure and Function of Sphingolipid- and Cholesterol-rich Membrane Rafts*

  2000cited by this paper
• Endocytosis deficiency of epidermal growth factor (EGF) receptor-ErbB2 heterodimers in response to EGF stimulation.

  1999influential reference
• The p185 neu -containing Glycoprotein Complex of a Microfilament-associated Signal Transduction Particle

  1999cited by this paper
• c‐erbB‐2/EGFR as dominant heterodimerization partners determine a motogenic phenotype in human breast cancer cells

  1999cited by this paper
• Regulated Migration of Epidermal Growth Factor Receptor from Caveolae*

  1999cited by this paper
• Spatial control of coated-pit dynamics in living cells

  1999cited by this paper
• Alternative Intracellular Routing of ErbB Receptors May Determine Signaling Potency*

  1998cited by this paper
• Heregulin Regulates Cytoskeletal Reorganization and Cell Migration through the p21-activated Kinase-1 via Phosphatidylinositol-3 Kinase*

  1998cited by this paper
• Differential endocytic routing of homo‐ and hetero‐dimeric ErbB tyrosine kinases confers signaling superiority to receptor heterodimers

  1998cited by this paper
• HER‐2/neu Signal Transduction in Human Breast and Ovarian Cancer

  1997cited by this paper
• Functional rafts in cell membranes

  1997influential reference
• Heregulin degradation in the absence of rapid receptor-mediated internalization.

  1997influential reference
• A subclass of tumor-inhibitory monoclonal antibodies to ErbB-2/HER2 blocks crosstalk with growth factor receptors

  1997influential reference
• All ErbB Receptors Other Than the Epidermal Growth Factor Receptor Are Endocytosis Impaired (*)

  1996influential reference
• Suppression and promotion of tumor growth by monoclonal antibodies to ErbB-2 differentially correlate with cellular uptake.

  1995cited by this paper
• Roles for a Cytoplasmic Tyrosine and Tyrosine Kinase Activity in the Interactions of Neu Receptors with Coated Pits (*)

  1995cited by this paper
• Coexpression of erbB2 and erbB3 proteins reconstitutes a high affinity receptor for heregulin.

  1994cited by this paper
• The carboxyl terminus of epidermal growth factor receptor/erbB-2 chimerae is internalization impaired.

  1993cited by this paper
• Internalization efficiency of the transferrin receptor.

  1992cited by this paper
• Sorting of GPI-anchored proteins to glycolipid-enriched membrane subdomains during transport to the apical cell surface.

  1992influential reference
• Requirements for the internalization of a murine monoclonal antibody directed against the HER-2/neu gene product c-erbB-2.

  1991cited by this paper
• Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer.

  1989cited by this paper

• Rapid plasma membrane reorganisation and endocytosis in HER2 breast cancer cells incubated with trastuzumab decorated polymer nanoparticles

  2026cites this paper
• Enhanced HER2 internalization by clathrin-dependent endocytosis in non-small cell lung cancer positive for HER2 mutations

  2025cites this paper
• Trastuzumab deruxtecan in the treatment of HER2-positive gastric cancer: a comprehensive review.

  2025cites this paper
• Innately Fluorescent Tetravalent Cytotoxic Conjugate TetraFHER2-vcMMAE Engages Aggregation-Dependent Endocytosis of HER2 for Enhanced Intracellular Drug Delivery

  2025cites this paper
• SNX10 deficiency impairs sensitivity to anti-HER2 antibody–drug conjugates via altering HER2 trafficking in HER2-positive breast cancer

  2025cites this paper
• Bystander effect in antibody-drug conjugates: navigating the fine line in tumor heterogeneity.

  2025cites this paper
• Low-density lipoprotein receptor-targeting chimeras for membrane protein degradation and enhanced drug delivery

  2025cites this paper
• Mechanisms of resistance to antibody-drug conjugates in cancer: molecular barriers and pharmacological solutions

  2025cites this paper
• 27-Hydroxycholesterol exacerbates hepatic insulin resistance via plasma membrane cholesterol remodeling.

  2025cites this paper
• Resistance to antibody–drug conjugates: A review

  2024cites this paper
• Elucidating molecular mechanisms and therapeutic synergy: irreversible HER2-TKI plus T-Dxd for enhanced anti-HER2 treatment of gastric cancer

  2024cites this paper
• A trafficking regulatory subnetwork governs αVβ6 integrin-HER2 cross-talk to control breast cancer invasion and drug resistance

  2024cites this paper
• Influence of Folate-Targeted Gold Nanoparticles on Subcellular Localization and Distribution into Lysosomes

  2023cites this paper
• A PERK-Specific Inhibitor Blocks Metastatic Progression by Limiting Integrated Stress Response-Dependent Survival of Quiescent Cancer Cells.

  2023cites this paper
• Using quantitative single molecule localization microscopy to optimize multivalent HER2-targeting ligands

  2023cites this paper
• EGFR trafficking: effect of dimerization, dynamics, and mutation

  2023cites this paper
• Internalization of Muscle-Specific Kinase Is Increased by Agrin and Independent of Kinase-Activity, Lrp4 and Dynamin

  2022cites this paper
• Mutant forms of EGFR promote HER2 trafficking through efficient formation of HER2-EGFR heterodimers.

  2022cites this paper
• Resistance to Trastuzumab

  2022cites this paper
• Extensive conformational and physical plasticity protects HER2-HER3 tumorigenic signaling

  2022cites this paper
• Direct Observation of Endocytosis Dynamics of Anti-ErbB Modified Single Nanocargoes.

  2022cites this paper
• Molecular Assessment of HER2 to Identify Signatures Associated with Therapy Response in HER2-Positive Breast Cancer

  2022cites this paper
• Accum™ Technology: A Novel Conjugable Primer for Onco-Immunotherapy

  2022cites this paper
• Impact of Endocytosis Mechanisms for the Receptors Targeted by the Currently Approved ADCs—A Necessity for Future ADC Research and Development

  2021influential citation
• Fucoidan/chitosan nanoparticles functionalized with anti-ErbB-2 target breast cancer cells and impair tumor growth in vivo.

  2021cites this paper
• Dynamics of Endocytosis and Degradation of Antibody-Drug Conjugate T-DM1 in HER2 Positive Cancer Cells

  2021cites this paper
• Impact of Endocytosis Mechanisms for the Receptors Targeted by the Currently Approved Antibody-Drug Conjugates (ADCs)—A Necessity for Future ADC Research and Development

  2021influential citation
• Autophagy blockade limits HER2+ breast cancer tumorigenesis by perturbing HER2 trafficking and promoting release via small extracellular vesicles.

  2021cites this paper
• Modular self-assembly system for development of oligomeric, highly internalizing and potent cytotoxic conjugates targeting fibroblast growth factor receptors

  2021cites this paper
• Systemic ligand-mimicking bioparticles cross the blood-brain barrier and reduce growth of intracranial triple-negative breast cancer using the human epidermal growth factor receptor 3 (HER3) to mediate both routes

  2021cites this paper
• Antigen Mass May Influence Trastuzumab Concentrations in Cerebrospinal Fluid After Intrathecal Administration

  2021cites this paper
• Quantification of EGFR-HER2 Heterodimers in HER2-Overexpressing Breast Cancer Cells Using Liquid-Phase Electron Microscopy

  2021cites this paper
• DDDT_A_344052 5135..5150

  2021cites this paper
• Classifying cell types with DNA-encoded ligand-receptor interactions on the cell membrane.

  2020cites this paper
• In Vivo Pretargeting Based on Cysteine-Selective Antibody Modification with IEDDA Bioorthogonal Handles for Click Chemistry.

  2020cites this paper
• Strategic Trastuzumab Mediated Crosslinking Driving Concomitant HER2 and HER3 Endocytosis and Degradation in Breast Cancer

  2020cites this paper
• Loss of HER2 and decreased T-DM1 efficacy in HER2 positive advanced breast cancer treated with dual HER2 blockade: the SePHER Study

  2020cites this paper
• Active targeting of gold nanoparticles as cancer therapeutics.

  2020cites this paper
• Correlative Fluorescence- and Electron Microscopy of Whole Breast Cancer Cells Reveals Different Distribution of ErbB2 Dependent on Underlying Actin

  2020cites this paper
• A Novel Proteomic Method Reveals NLS Tagging of T-DM1 Contravenes Classical Nuclear Transport in a Model of HER2-Positive Breast Cancer

  2020cites this paper
• CD13 as a new tumor target for antibody-drug conjugates: validation with the conjugate MI130110

  2020cites this paper
• Hypoxia Attenuates Trastuzumab Uptake and Trastuzumab-Emtansine (T-DM1) Cytotoxicity through Redistribution of Phosphorylated Caveolin-1

  2020cites this paper
• Regulation of the EGFR/ErbB signalling by clathrin in response to various ligands in hepatocellular carcinoma cell lines

  2020cites this paper
• Determining the Efficiency of Single Molecule Quantum Dot Labeling of HER2 in Breast Cancer Cells.

  2020cites this paper
• Improving Receptor-Mediated Intracellular Access and Accumulation of Antibody Therapeutics—The Tale of HER2

  2020cites this paper
• HER2 Nuclear Translocation and Decreased T-DM1 Efficacy in HER2 Positive Advanced Breast Cancer Treated with Dual HER2 Blockade. The SePHER Study.

  2020cites this paper
• ISGylation drives basal breast tumour progression by promoting EGFR recycling and Akt signalling

  2019cites this paper
• Homo- and Heteroassociations Drive Activation of ErbB3

  2019cites this paper
• HER2-Overexpressing/Amplified Breast Cancer as a Testing Ground for Antibody–Drug Conjugate Drug Development in Solid Tumors

  2019cites this paper
• Cullin‐3/KCTD10 E3 complex is essential for Rac1 activation through RhoB degradation in human epidermal growth factor receptor 2‐positive breast cancer cells

  2019cites this paper
• SORLA regulates endosomal trafficking and oncogenic fitness of HER2

  2019cites this paper
• HER2-targeted PET imaging and therapy of hyaluronan-masked HER2-overexpressing breast cancer.

  2019cites this paper
• HER2 Cancer Protrusion Growth Signaling Regulated by Unhindered, Localized Filopodial Dynamics

  2019cites this paper
• Mathematical modeling of drug-induced receptor internalization in the HER2-positive SKBR3 breast cancer cell-line

  2019cites this paper
• The Cause of ErbB2 Receptor Resistance to Downregulation

  2018cites this paper
• Caveolin-1 mediates cellular distribution of HER2 and affects trastuzumab binding and therapeutic efficacy

  2018cites this paper
• New insights into receptor trafficking in human cancer

  2018cites this paper
• Multivalent exposure of trastuzumab on iron oxide nanoparticles improves antitumor potential and reduces resistance in HER2-positive breast cancer cells

  2018cites this paper
• HER2-targeted gold nanoparticles potentially overcome resistance to trastuzumab in gastric cancer.

  2018cites this paper
• SORLA-driven endosomal trafficking regulates the oncogenic fitness of HER2

  2018cites this paper
• Effects of Hsp90 inhibition and/or PKC activation on ErbB2 in MDA-MB-453 cells

  2018cites this paper
• Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine 1469 Novel Roles of the Ack 1 Kinase in Epithelial Biology

  2018cites this paper
• Merlin/ERM proteins regulate growth factor-induced macropinocytosis and receptor recycling by organizing the plasma membrane:cytoskeleton interface

  2018cites this paper
• Quantifying Cellular Internalization with a Fluorescent Click Sensor.

  2018cites this paper
• Protein kinase C mediated internalization of ErbB2 is independent of clathrin, ubiquitination and Hsp90 dissociation

  2018cites this paper
• Inhibition of ezrin causes PKCα-mediated internalization of erbb2/HER2 tyrosine kinase in breast cancer cells

  2018cites this paper
• Interplay of Endocytosis and Growth Factor Receptor Signalling.

  2018cites this paper
• Virus-like particle display of HER2 induces potent anti-cancer responses

  2018cites this paper
• Aberrant endocytosis leads to the loss of normal mitotic spindle orientation during epithelial glandular morphogenesis

  2018cites this paper
• Dual targeting of HER2-positive breast cancer with trastuzumab emtansine and pertuzumab: understanding clinical trial results

  2018cites this paper
• Molecular and Transcriptional Signatures for ErbB2-Induced Invasion

  2018cites this paper
• HER2 signaling regulates HER2 localization and membrane retention

  2017cites this paper
• Systems modeling of quantitative kinetic data identifies receptor tyrosine kinase-specific resistance mechanisms to MAPK pathway inhibition in cancer

  2017cites this paper
• The scaffolding protein NHERF1 regulates the stability and activity of the tyrosine kinase HER2

  2017cites this paper
• Transactivation of the epidermal growth factor receptor in responses to myocardial stress and cardioprotection.

  2017cites this paper
• Click Therapy: Novel Concept in Pretargeting Drug Delivery

  2017cites this paper
• Antibody-Drug Conjugates

  2017cites this paper
• Nanoparticles for live cell microscopy: A surface-enhanced Raman scattering perspective

  2017cites this paper
• Cooperative but distinct early co-signaling events originate from ERBB2 and ERBB1 receptors upon trastuzumab treatment in breast cancer cells

  2017cites this paper
• Bifunctional Toxin DARP-LoPE Based on the Her2-Specific Innovative Module of a Non-Immunoglobulin Scaffold as a Promising Agent for Theranostics

  2017cites this paper
• Therapeutic potential of an anti-HER2 single chain antibody–DM1 conjugates for the treatment of HER2-positive cancer

  2017cites this paper
• Superresolution Imaging of Clinical Formalin Fixed Paraffin Embedded Breast Cancer with Single Molecule Localization Microscopy

  2017cites this paper
• Unique therapeutic properties and preparation methodology of multivalent rituximab‐lipid nanoparticles

  2017cites this paper
• A novel immuno-gold labeling protocol for nanobody-based detection of HER2 in breast cancer cells using immuno-electron microscopy.

  2017cites this paper
• Cell surface dynamics and cellular distribution of endogenous FcRn

  2017cites this paper
• Effect of trastuzumab on the micellization properties, endocytic pathways and antitumor activities of polyurethane-based drug delivery system

  2017cites this paper
• Hyaluronic Acid in Vascular and Immune Homeostasis during Normal Pregnancy and Preeclampsia

  2016cites this paper
• Identification of an HSP90 modulated multi-step process for ERBB2 degradation in breast cancer cells

  2016cites this paper
• PMCA2 regulates HER2 protein kinase localization and signaling and promotes HER2-mediated breast cancer

  2016cites this paper
• High cell-surface density of HER2 deforms cell membranes

  2016cites this paper
• A combination of two antibodies recognizing non‐overlapping epitopes of HER2 induces kinase activity‐dependent internalization of HER2

  2016cites this paper
• Septin oligomerization regulates persistent expression of ErbB2/HER2 in gastric cancer cells.

  2016cites this paper
• 17AAG-induced internalisation of HER2-specific Affibody molecules

  2016cites this paper
• Internalization and Recycling of the HER2 Receptor on Human Breast Adenocarcinoma Cells Treated with Targeted Phototoxic Protein DARPinminiSOG

  2015cites this paper
• Small Sized EGFR1 and HER2 Specific Bifunctional Antibody for Targeted Cancer Therapy

  2015cites this paper
• Local variations of HER2 dimerization in breast cancer cells discovered by correlative fluorescence and liquid electron microscopy

  2015cites this paper
• Endocytosis and Endosomal Sorting of Receptor Tyrosine Kinases

  2015cites this paper
• A HER2-specific Modified Fc Fragment (Fcab) Induces Antitumor Effects Through Degradation of HER2 and Apoptosis

  2015cites this paper
• Strategies and Advancement in Antibody-Drug Conjugate Optimization for Targeted Cancer Therapeutics

  2015cites this paper
• Epidermal growth factor–stimulated Akt phosphorylation requires clathrin or ErbB2 but not receptor endocytosis

  2015influential citation